Patent Assignment
Reel/Frame 069833/0155
Release of Security Interest
Recorded: 2024-10-03
Pages: 41
Assignor
ABW CYCLOPS SPV LP
Executed: 2024-08-30
Assignee
CYMABAY THERAPEUTICS, INC.
7575 GATEWAY BLVD, SUITE 110, NEWARK, CALIFORNIA, 94560
Covered Properties
(58)
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
Novel Lysine Salts of 4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acid Derivatives
Benzoazepin-Oxy-Acetic Acid Derivatives as Ppar-Delta Agonists Used for the Increase of Hdl-C, Lower Ldl-C and Lower Cholesterol
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
Benzoazepin-Oxy-Acetic Acid Derivatives as Ppar-Delta Agonists Used for the Increase of Hdl-C, Lower Ldl-C and Lower Cholesterol
Novel Lysine Salts of 4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acid Derivatives
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
4-(Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
4-((Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
Treatment of Intrahepatic Cholestatic Diseases
Treatment of NAFLD and NASH
4-(Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
Treatment of NAFLD and NASH
Treatment of Intrahepatic Cholestatic Diseases
Treatment of NAFLD and NASH
Treatment of intrahepatic cholestatic diseases
Treatment of intrahepatic cholestatic diseases
Treatment of NAFLD and NASH
Treatment of intrahepatic cholestatic diseases
Methods of Reducing Small, Dense Ldl Particles
Treatment of intrahepatic cholestatic diseases
Treatment of NAFLD and NASH
4-(Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
Application:
16/292,406 →
Publication:
US 2019/0192475
Treatment of intrahepatic cholestatic diseases
Treatment of NAFLD and NASH
Treatment of intrahepatic cholestatic diseases
Treatment of intrahepatic cholestatic diseases
Combination treatment of NAFLD and NASH
Application:
16/682,408 →
Publication:
US 2020/0155650
Treatment of obesity and its complications
Application:
16/682,525 →
Publication:
US 2020/0155487
Treatment of Nafld and Nash
Treatment of intrahepatic cholestatic diseases
Treatment of Intrahepatic Cholestatic Diseases
Treatment of intrahepatic cholestatic diseases
Treatment of alcoholic liver disease
Application:
17/096,217 →
Publication:
US 2021/0145774
Treatment of intestinal barrier dysfunction and associated diseases
Application:
17/096,385 →
Publication:
US 2021/0145775
Treatment of cholestatic pruritus
Application:
17/128,195 →
Publication:
US 2021/0283078
Treatment of intrahepatic cholestatic diseases
Treatment of cholangiopathies
Application:
17/588,273 →
Publication:
US 2022/0241228
4-(Phenoxyalkyl)Thio)-Phenoxyacetic Acids and Analogs
Application:
18/120,484 →
Publication:
US 2023/0210808
Treatment of uremic pruritus
Application:
18/423,217 →
Publication:
US 2024/0252499
Treatment of chronic pruritic dermatoses
Application:
18/423,232 →
Publication:
US 2024/0252500
4-(Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
Application:
60/504,089 →
4-(Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
Application:
60/504,146 →
Novel lysine salts of 4- ((phenoxyalkyl) thio) -phenoxyacetic acid derivatives
Application:
60/717,137 →
Treatment of intrahepatic cholestatic diseases
Application:
61/968,037 →
Treatment of intrahepatic cholestatic diseases
Application:
62/343,688 →
Treatment of intrahepatic cholestatic diseases
Application:
62/532,571 →
Treatment of cholestatic pruritus
Application:
62/563,395 →
Treatment of intrahepatic cholestatic diseases
Application:
62/563,491 →
Treatment of cholangiopathies
Application:
63/144,355 →
Treatment of uremic pruritus
Application:
63/441,822 →
Treatment of chronic pruritic dermatoses
Application:
63/441,823 →
Process for Making Seladelpar
Application:
63/677,935 →
Methods for Treating Liver Disease
Application:
63/677,952 →
Methods for Treating Liver Disease
Application:
63/683,179 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 4, 2005
From: KUO, GEE-HONG; ZHANG, RUI; WANG, AIHUA; DEANGELIS, ALAN R.
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 015523/0620 →
Assignment of Assignor's Interest
Feb 8, 2005
From: KUO, GEE-HONG; ZHANG, RUI; WANG, AIHUA; DEANGELIS, ALAN R.
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 015681/0770 →
Assignment of Assignor's Interest
Sep 13, 2006
From: ABDEL-MAGID, AHMED; MEHRMAN, STEVEN; ROESSLER, ARMIN
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 018243/0069 →
Assignment of Assignor's Interest
Apr 23, 2007
From: KUO, GEE-HONG; ZHANG, YAN; SHEN, LAN; LU, SONGFENG
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 019191/0962 →
Assignment of Assignor's Interest
Apr 9, 2015
From: BOUDES, POL; MCWHERTER, CHARLES A.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 035367/0789 →
Assignment of Assignor's Interest
Sep 1, 2015
From: BOUDES, POL; MCWHERTER, CHARLES A.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036470/0849 →
Assignment of Intellectual Property Security Interest
Nov 18, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, SUCCESSOR AGENT
Reel/Frame 037146/0250 →
Nunc Pro Tunc Assignment
Apr 12, 2016
From: CHOI, YUN-JUNG; MARTIN, ROBERT; MCWHERTER, CHARLES; WANG, XUEYAN
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 038252/0464 →